Noom Med vs NovoCare Pharmacy (Wegovy) (2026): prices, structure, verdict
On semaglutide, Noom Med↗ is cheaper: $199 versus $349 a month all-in — a $150 monthly gap, $1,800 across a year of maintenance dosing.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
Noom Med
- Tirzepatide all-in
- not offered
- Semaglutide all-in
- $199/mo · flat
- 12-mo tirzepatide (best path)
- —
- Membership
- none
- Shipping
- included
- Commitment
- 12-week cycles
- Cancellation
- 12-week billing cycles
- Pharmacy
- ✔ Tailor Made Compounding (named)
- States
- most states
- Insurance
- no
- Evidence
- source-verified · 2026-08-08
- Tirzepatide all-in
- not offered
- Semaglutide all-in
- $349/mo · flat
- 12-mo tirzepatide (best path)
- —
- Membership
- none
- Shipping
- included (or retail via savings card)
- Commitment
- none
- Cancellation
- no subscription
- Pharmacy
- ✔ Novo Nordisk direct / retail partners
- States
- 50 states
- Insurance
- no
- Evidence
- source-verified · 2026-08-10
The two records, condensed
Noom Med: the record, condensed
Start with the load-bearing figure: $199 a month, all-in, is what Noom Med charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $199 is the whole subscription, which makes Noom Med unusually easy to compare and unusually easy to leave.
To place the number: #12 of 20 verified programs, with the floor $66/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $150 a month. A year at this figure: $2,388 monthly-billed.
Operationally at Noom Med: shipping included; commitment 12-week cycles; cancellation 12-week billing cycles; pharmacy named (Tailor Made Compounding (named)); states: most states; evidence source-verified, captured 2026-08-08. The full record with source and archive links: the Noom Med page · visit Noom Med ↗
NovoCare Pharmacy (Wegovy): the record, condensed
Start with the load-bearing figure: $349 a month, all-in, is what NovoCare Pharmacy (Wegovy) charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $349 is the whole subscription, which makes NovoCare Pharmacy (Wegovy) unusually easy to compare and unusually easy to leave.
To place the number: #0 of 20 verified programs, with the floor $216/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth nothing a month — at which point brand deserves the first look. A year at this figure: $4,188 monthly-billed.
Operationally at NovoCare Pharmacy (Wegovy): shipping included (or retail via savings card); commitment none; cancellation no subscription; pharmacy named (Novo Nordisk direct / retail partners); states: 50 states; evidence source-verified, captured 2026-08-10. The full record with source and archive links: the NovoCare Pharmacy (Wegovy) page · visit NovoCare Pharmacy (Wegovy) ↗
Semaglutide: the duel in full
Put the two semaglutide figures side by side and hold them there: Noom Med at $199, NovoCare Pharmacy (Wegovy) at $349 — a $150 monthly spread that compounds to $1,800 over a maintenance year and $3,600 over two.
Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $150 gap is exactly what it appears to be.
Translate the $150/month spread into medication: $1,800 a year equals roughly 9.0 months of therapy at the cheaper program’s rate. That is the honest unit for gaps in this market — months of treatment, not abstract dollars — and it is why small-looking monthly differences decide long courses.
On best published rate — the lower of each program’s month-to-month price and its labeled 12-month-plan rate, which is the sort most price roundups quietly run — the duel reads: Noom Med $199/mo month-to-month versus NovoCare Pharmacy (Wegovy) $349/mo month-to-month. Same winner on both bases — Noom Med leads whether you compare month-to-month prices or committed-plan rates, which makes this one of the cleaner verdicts in the index. Prepaid rates are upfront commitments with refund terms to verify before they count.
Three, six, twelve, twenty-four months — best path each way
3 months: Noom Med $597 monthly; NovoCare Pharmacy (Wegovy) $1,047 monthly — best path favors Noom Med by $450. 6 months: Noom Med $1,194 monthly; NovoCare Pharmacy (Wegovy) $2,094 monthly — best path favors Noom Med by $900. 12 months: Noom Med $2,388 monthly; NovoCare Pharmacy (Wegovy) $4,188 monthly — best path favors Noom Med by $1,800. 24 months: Noom Med $4,776 monthly; NovoCare Pharmacy (Wegovy) $8,376 monthly — best path favors Noom Med by $3,600.
Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.
Everything besides the price
Coverage: Noom Med publishes “most states”; NovoCare Pharmacy (Wegovy) publishes “50 states” — for anything short of an explicit 50-state claim, intake is the final word.
Pharmacy transparency: both name fulfillment (Tailor Made Compounding (named) / Novo Nordisk direct / retail partners) — rare in this market, and it makes both independently checkable.
Exit terms: Noom Med — 12-week cycles; 12-week billing cycles. NovoCare Pharmacy (Wegovy) — none; no subscription.
Evidence: Noom Med source-verified (captured 2026-08-08); NovoCare Pharmacy (Wegovy) source-verified (2026-08-10).
A rule that has held across this index: disclosure predicts disclosure. Whichever of these two publishes more — pharmacies, states, exit terms — is usually the one whose invoice matches its ad.
Switching between Noom Med and NovoCare Pharmacy (Wegovy)
Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Noom Med: 12-week billing cycles; NovoCare Pharmacy (Wegovy): no subscription) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.
Which one, for whom
Cheapest semaglutide: Noom Med ($199).
Reduced to a sentence each: Noom Med is the arithmetic answer at $199 all-in; NovoCare Pharmacy (Wegovy) is the answer only if what its extra $150/month buys — its structural particulars — appears on your personal ledger; and insurance coverage, wherever it exists, is the answer that beats both. The calculator settles the residue at your own horizon.
Verdicts are computed from the records above — recompute them from the dataset. Full profiles: Noom Med · NovoCare Pharmacy (Wegovy).
Frequently asked
Which is cheaper, Noom Med or NovoCare Pharmacy (Wegovy)?
On semaglutide, Noom Med is cheaper: $199 versus $349 a month all-in — a $150 monthly gap, $1,800 across a year of maintenance dosing.
Is there a membership fee at Noom Med or NovoCare Pharmacy (Wegovy)?
Noom Med: none. NovoCare Pharmacy (Wegovy): none.
Where do these numbers come from?
From each provider's own published pages, captured 2026-08-08 (Noom Med) and 2026-08-10 (NovoCare Pharmacy (Wegovy)), normalized to the all-in maintenance basis and archived. Full records: the provider pages and the public dataset.
What does a year of semaglutide cost at Noom Med vs NovoCare Pharmacy (Wegovy)?
Noom Med: $2,388 monthly-billed. NovoCare Pharmacy (Wegovy): $4,188. Best-path difference: $1,800 in favor of Noom Med.
Is Noom Med or NovoCare Pharmacy (Wegovy) dose-flat?
Noom Med: yes — the price holds across the titration ladder. NovoCare Pharmacy (Wegovy): yes — flat across doses. Flat pricing turns the advertised number into a ceiling; tiered pricing makes it a floor.
Can I check both Noom Med and NovoCare Pharmacy (Wegovy) against their sources?
Yes — that is the design. Each record carries a capture date (2026-08-08 / 2026-08-10), a source link, and an archive link in the database; the figures on this page regenerate from those records, so any discrepancy you find is reportable and fixable sitewide in one pass.
What states do Noom Med and NovoCare Pharmacy (Wegovy) serve?
Noom Med: most states. NovoCare Pharmacy (Wegovy): 50 states. Telehealth availability rides on clinician licensure and pharmacy permits, so for anything short of an explicit 50-state claim the enrollment flow is the final word; the state-by-state index adds the known exceptions.
Is shipping included at Noom Med and NovoCare Pharmacy (Wegovy)?
Noom Med: included. NovoCare Pharmacy (Wegovy): included (or retail via savings card). Cold-chain delivery is a real cost; programs that fold it into the all-in figure remove a checkout surprise, and any separate shipping line belongs in your comparison math before the prices above are treated as equivalent.
Which is more transparent, Noom Med or NovoCare Pharmacy (Wegovy)?
On the checkable axes: pharmacy named — Noom Med yes (Tailor Made Compounding (named)), NovoCare Pharmacy (Wegovy) yes (Novo Nordisk direct / retail partners); state list — Noom Med published, NovoCare Pharmacy (Wegovy) published; cancellation terms — Noom Med published, NovoCare Pharmacy (Wegovy) published; evidence — source-verified vs source-verified. Disclosure predicts disclosure in this market, and the axis where one of these two goes quiet is usually where your intake questions should get loud.